FDA Import Refusal 799-1497664-1/11/1 — Santen Pharmaceutical Co. Ltd.
The FDA refused shipment 799-1497664-1/11/1 from Santen Pharmaceutical Co. Ltd. (Japan) on Mar 30, 2021. The refused product falls under Drugs and Biologics — ANTI-HYPERTENSIVE N.E.C.. Cited charges: 118,3280,342 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 30, 2021
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 62CDL99 ANTI-HYPERTENSIVE N.E.C.
- Charges
- 118,3280,342